Li D , Mallory T. AFP-L3:a new generation of tumor marker for hepatocellular carcinoma[J].Clin Chim Acta,2001,3I3:15-19.
[4]
Infectious disease and parasitic disease society and Chinese society of Hepatology of Chinese Medical Association. Plan for prevention and treatment of viral hepatitis[J]. Chin J Hepatol,2000,8:324-329. （In Chinese）
Chinese Anti-Cancer Association. The new criteria for diagnosis and treatment of common malignant tumors【M】. Beijing: Beijing Medical University and Peking Union Medical College press, 1999:22-23. （In Chinese）
Chen SC,Huang DZ. Analysis of surgical treatment of primary liver cancer[J]．China Trop Med,2006,10(6):1778-1779.（In Chinese）
[11]
(陈圣才,黄定洲.原发性肝癌的外科治疗分析[J].中国热带医学,2009,9(9):1765.)
[12]
Trinchet J C,Alperovitch A,Bedossa P,et al. Epidemiology,prevention,screening and diagnosis of hepato cellular carcinoma [J].Bull Cancer,2009,96（1）:35-43.
[13]
Zan HM,Feng L. Serum gamma-glutamyl transpeptidase (GGT) activity in liver cancer diagnosis significance[J]. J Prac Med,2005,12(9):2347-2349. （In Chinese）
Chen ZW,Ye XG,He MJ,et al. Study on the combined detection of AFP,GGT and spiral CT hepatic arteriography for diagnosis of primary hepatic cancer[J]．China Trop Med,2006,10(6):1778-1779.（In Chinese）
Zeng YL,Mao HN. Serum AFP, AKP and GGT between change and the prognosis of hepatocellular carcinoma after transcatheter arterial chemoembolization[J]. China Trop Med,2011,11(11):1389-1390.（In Chinese）
You SL,Xin SJ. 229 cases of AFP was significantly increased in patients with liver disease clinical analysis[J]. Prac Prev Med,2006,13:1613-1614. （In Chinese）
